Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
基本信息
结项摘要
Endoglin(EDG)是肿瘤新生血管内皮细胞膜表面蛋白，是肿瘤血管生成的标志性分子之一。树突状细胞(DC)是体内抗原提呈功能最强的抗原提呈细胞。本研究拟在完成省自然科学基金子课题"抗肺癌DC疫苗研究"和国家自然科学基金项目的子课题"EndoglinDNA疫苗诱导抗癌免疫反应"的基础上，以体内癌细胞和肿瘤新生血管内皮细胞为直接目标，依据肿瘤抗原提呈给T细胞的机理，将转染鼠EDG表达基因的原代培养的肺癌患者癌细胞与患者的DC融合成杂交细胞，该细胞与患者的T细胞混合培养诱生特异性CTL，完成体外细胞毒实验。用原代培养的人肺癌细胞与重建肺癌病人免疫系统的SCID鼠建立肿瘤动物模型，将转染鼠EDG基因的荷瘤鼠癌细胞和荷瘤鼠DC融合成杂交细胞后，再与荷瘤鼠T细胞混合培养，诱生扩增的CTL回输至荷人肺癌SCID鼠体内，研究其对体内癌细胞和肿瘤血管内皮细胞直接产生"双重"细胞毒作用所诱导的抗癌效应。
项目摘要
项目成果
{{i.achievement_title}}
{{i.achievement_title}}
暂无此项成果
数据更新时间：2023-05-31
其他相关文献
Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer
Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer
Influence of Forging Temperature on the Microstructures and Mechanical Properties of a Multi-Directionally Forged Al-Cu-Li Alloy
Influence of Forging Temperature on the Microstructures and Mechanical Properties of a Multi-Directionally Forged Al-Cu-Li Alloy
Identification and Antioxidant Activity of a Novel Peptide from Baijiu
Identification and Antioxidant Activity of a Novel Peptide from Baijiu
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
Glycyrrhetinic Acid Protects Renal Tubular Cells against Oxidative Injury via Reciprocal Regulation of JNK-Connexin 43-Thioredoxin 1 Signaling
Glycyrrhetinic Acid Protects Renal Tubular Cells against Oxidative Injury via Reciprocal Regulation of JNK-Connexin 43-Thioredoxin 1 Signaling
周源的其他基金
相似国自然基金
GP73+AFP+HCC/DC杂交细胞诱生特异性抗人肝癌CTL疫苗的研究
人肺癌DC疫苗诱导特异性抗肿瘤免疫效应机制的研究
重组HSV-1靶向激活DC诱导CTL抗肺癌免疫应答的实验研究
Endoglin 适配体/IP-10生物反应器定向募集特异性CTL抗肿瘤研究